Covered recipient · General Payments record
ALFREDO PARDO
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Family
General Payments · PY2023–2024
$404.30
- Reported across 22 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $289.42 | 16 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| PFIZER INC. | $76.57 | 4 |
| Novo Nordisk AS | $48.52 | 3 |
| Lilly USA, LLC | $44.79 | 3 |
| ViiV Healthcare Company | $42.56 | 2 |
| E.R. Squibb & Sons, L.L.C. | $24.90 | 1 |
| Exact Sciences Corporation | $20.16 | 1 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $17.19 | 1 |
| BAXTER HEALTHCARE | $14.73 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (16)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Baxter Healthcare | $14.73 | 09/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1120591527 | CMS |
| E.R. Squibb & Sons, L.L.C. | $24.90 | 05/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101234291 | CMS |
| Exact Sciences Corporation | $20.16 | 05/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114822500 | CMS |
| Lilly USA, LLC | $14.76 | 03/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135494776 | CMS |
| Lilly USA, LLC | $15.83 | 04/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135444731 | CMS |
| Lilly USA, LLC | $14.20 | 08/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135494778 | CMS |
| Novo Nordisk Inc | $15.70 | 02/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100577930 | CMS |
| Novo Nordisk Inc | $15.54 | 07/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100563708 | CMS |
| Novo Nordisk Inc | $17.28 | 10/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100477590 | CMS |
| PFIZER INC. | $15.34 | 01/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1132001101 | CMS |
| PFIZER INC. | $16.48 | 01/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1132001103 | CMS |
| PFIZER INC. | $24.84 | 05/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1132001105 | CMS |
| PFIZER INC. | $19.91 | 12/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131239727 | CMS |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $17.19 | 08/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153597473 | CMS |
| ViiV Healthcare Company | $16.25 | 05/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1112823347 | CMS |
| ViiV Healthcare Company | $26.31 | 12/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1112767092 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2023, 2024
- Source files
- Dataset page · Bulk file · PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.